These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Recurrent copy number alterations in low-grade and anaplastic pleomorphic xanthoastrocytoma with and without BRAF V600E mutation. Vaubel RA; Caron AA; Yamada S; Decker PA; Eckel Passow JE; Rodriguez FJ; Nageswara Rao AA; Lachance D; Parney I; Jenkins R; Giannini C Brain Pathol; 2018 Mar; 28(2):172-182. PubMed ID: 28181325 [TBL] [Abstract][Full Text] [Related]
7. BRAF-mutated pleomorphic xanthoastrocytoma is associated with temporal location, reticulin fiber deposition and CD34 expression. Koelsche C; Sahm F; Wöhrer A; Jeibmann A; Schittenhelm J; Kohlhof P; Preusser M; Romeike B; Dohmen-Scheufler H; Hartmann C; Mittelbronn M; Becker A; von Deimling A; Capper D Brain Pathol; 2014 Apr; 24(3):221-9. PubMed ID: 24345274 [TBL] [Abstract][Full Text] [Related]
8. [BRAF V600E mutation and clinicopathologic characteristics in 250 cases of brain tumors associated with epilepsy]. Qi XL; Yao K; Duan ZJ; Bian Y; Ma Z; Piao YS; Gong LP Zhonghua Bing Li Xue Za Zhi; 2018 Sep; 47(9):664-670. PubMed ID: 30220118 [No Abstract] [Full Text] [Related]
9. Composite pleomorphic xanthoastrocytoma-epithelioid glioneuronal tumor with BRAF V600E mutation - report of three cases. Aisner DL; Newell KL; Pollack AG; Kleinschmidt-Demasters BK; Steinberg GK; Smyth LT; Vogel H Clin Neuropathol; 2014; 33(2):112-21. PubMed ID: 24321241 [TBL] [Abstract][Full Text] [Related]
10. Biology and grading of pleomorphic xanthoastrocytoma-what have we learned about it? Vaubel R; Zschernack V; Tran QT; Jenkins S; Caron A; Milosevic D; Smadbeck J; Vasmatzis G; Kandels D; Gnekow A; Kramm C; Jenkins R; Kipp BR; Rodriguez FJ; Orr BA; Pietsch T; Giannini C Brain Pathol; 2021 Jan; 31(1):20-32. PubMed ID: 32619305 [TBL] [Abstract][Full Text] [Related]
11. BRAF V600E, TERT promoter mutations and CDKN2A/B homozygous deletions are frequent in epithelioid glioblastomas: a histological and molecular analysis focusing on intratumoral heterogeneity. Nakajima N; Nobusawa S; Nakata S; Nakada M; Yamazaki T; Matsumura N; Harada K; Matsuda H; Funata N; Nagai S; Nakamura H; Sasaki A; Akimoto J; Hirato J; Yokoo H Brain Pathol; 2018 Sep; 28(5):663-673. PubMed ID: 29105198 [TBL] [Abstract][Full Text] [Related]
12. Composite pleomorphic xanthoastrocytoma and ganglioglioma: report of four cases and review of the literature. Perry A; Giannini C; Scheithauer BW; Rojiani AM; Yachnis AT; Seo IS; Johnson PC; Kho J; Shapiro S Am J Surg Pathol; 1997 Jul; 21(7):763-71. PubMed ID: 9236832 [TBL] [Abstract][Full Text] [Related]
13. Dysembryoplastic neuroepithelial tumors share with pleomorphic xanthoastrocytomas and gangliogliomas BRAF(V600E) mutation and expression. Chappé C; Padovani L; Scavarda D; Forest F; Nanni-Metellus I; Loundou A; Mercurio S; Fina F; Lena G; Colin C; Figarella-Branger D Brain Pathol; 2013 Sep; 23(5):574-83. PubMed ID: 23442159 [TBL] [Abstract][Full Text] [Related]
15. Molecular features of pleomorphic xanthoastrocytoma. Zou H; Duan Y; Wei D; Zhang Y; Dai J; Li J; Li X; Zhou J; Liu Z; Jin Z; Zhang Z; Yu Y; Hu Z Hum Pathol; 2019 Apr; 86():38-48. PubMed ID: 30496796 [TBL] [Abstract][Full Text] [Related]
16. BRAF V600E, TERT, and IDH2 Mutations in Pleomorphic Xanthoastrocytoma: Observations from a Large Case-Series Study. Ma C; Feng R; Chen H; Hameed NUF; Aibaidula A; Song Y; Wu J World Neurosurg; 2018 Dec; 120():e1225-e1233. PubMed ID: 30240866 [TBL] [Abstract][Full Text] [Related]
17. The genetic landscape of ganglioglioma. Pekmezci M; Villanueva-Meyer JE; Goode B; Van Ziffle J; Onodera C; Grenert JP; Bastian BC; Chamyan G; Maher OM; Khatib Z; Kleinschmidt-DeMasters BK; Samuel D; Mueller S; Banerjee A; Clarke JL; Cooney T; Torkildson J; Gupta N; Theodosopoulos P; Chang EF; Berger M; Bollen AW; Perry A; Tihan T; Solomon DA Acta Neuropathol Commun; 2018 Jun; 6(1):47. PubMed ID: 29880043 [TBL] [Abstract][Full Text] [Related]
18. Cyclin D1 expression in ganglioglioma, pleomorphic xanthoastrocytoma and pilocytic astrocytoma. Forest F; Dal Col P; Laville D; Court A; Rillardon M; Ramirez C; Rivoirard R; Stephan JL; Vassal F; Péoc'h M Exp Mol Pathol; 2021 Aug; 121():104652. PubMed ID: 34022185 [TBL] [Abstract][Full Text] [Related]
19. BRAF mutation and anaplasia may be predictive factors of progression-free survival in adult pleomorphic xanthoastrocytoma. Tabouret E; Bequet C; Denicolaï E; Barrié M; Nanni I; Metellus P; Dufour H; Chinot O; Figarella-Branger D Eur J Surg Oncol; 2015 Dec; 41(12):1685-90. PubMed ID: 26454767 [TBL] [Abstract][Full Text] [Related]
20. Pleomorphic xanthoastrocytoma, anaplastic pleomorphic xanthoastrocytoma, and epithelioid glioblastoma: Case series with clinical characteristics, molecular features and progression relationship. Lin Z; Yang R; Zheng H; Li Z; Yi G; Wu Q; Yang C; Huang G Clin Neurol Neurosurg; 2022 Oct; 221():107379. PubMed ID: 35932588 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]